Clinical Trial Results:
Etude de la valeur prédictive de la réversibilité de l’obstruction bronchique sur l’efficacité d’un traitement d’un mois par indacatérol (Onbrez Breezhaler) 150 µg une fois par jour chez des patients atteints d’une BPCO modérée à sévère.
Summary
|
|
EudraCT number |
2010-022831-12 |
Trial protocol |
FR |
Global completion date |
30 May 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
13 Oct 2016
|
First version publication date |
13 Oct 2016
|
Other versions |
|
Summary report(s) |
CQAB149BFR01 NovCTR |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.